CAPITAL COUNSEL LLC/NY - ISIS PHARMACEUTICALS INC ownership

ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPITAL COUNSEL LLC/NY ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$525,000
-29.8%
13,0000.0%0.03%
-27.0%
Q2 2015$748,000
-9.7%
13,0000.0%0.04%
-5.1%
Q1 2015$828,000
+3.1%
13,0000.0%0.04%
+2.6%
Q4 2014$803,000
+59.0%
13,0000.0%0.04%
+35.7%
Q3 2014$505,000
+22.3%
13,000
+8.3%
0.03%
+21.7%
Q2 2014$413,00012,0000.02%
Other shareholders

There were no reported owners of ISIS PHARMACEUTICALS INC in Q4 2014.

NameSharesValueWeighting ↓
View complete list of ISIS PHARMACEUTICALS INC shareholders